BVF INC/IL Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001056807

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q2 2024 · 60 positions · Total reported value $3.57B · Top-10 concentration 61.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 34.8% · 5 new · 9 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.0% · vs SPY +11.2% · Prev Value $3.14B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, BVF INC/IL disclosed 60 equity positions with a combined reported value of $3.57B. The filing implies a focused portfolio: its ten largest positions account for 61.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were MLTX ($956.40M), RVMD ($232.13M), KYMR ($154.08M). By sector, the heaviest allocations are Health Care 86.4%, Materials 0.0%. Versus the prior quarter, allocation shifted toward Health Care (+1.2pp) and away from Other (-1.1pp).

Versus the prior quarter, BVF INC/IL opened 5 new positions, trimmed 9 and fully exited 2, a turnover rate of 34.8% of positions. The portfolio's overlap with the prior quarter was 85% of names.

The largest new positions opened in Q2 2024 were AXSM ($76.88M), CELC ($56.77M), AGIO ($51.32M).

Of the 2 positions fully exited versus the prior quarter, the largest were SNDX ($44.62M), DCTH ($5.73M), LXRX ($4.05M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • AXSM AXSOME THERAPEUTICS INC. · $76.88M
  • CELC CELCUITY INC · $56.77M
  • AGIO AGIOS PHARMACEUTICALS INC COMP · $51.32M
  • FHTX FOGHORN THERAPEUTICS INC COM · $30.49M

Fully Exited (vs previous quarter)

  • SNDX SYNDAX PHARMACEUTICALS INC · prev qtr: $44.62M
  • DCTH DELCATH SYS INC · prev qtr: $5.73M
  • LXRX LEXICON PHARMACEUTICALS INC · prev qtr: $4.05M
  • ANTX AN2 THERAPEUTICS INC · prev qtr: $4.03M
  • KRON KRONOS BIO INC · prev qtr: $3.78M
  • CRVS CORVUS PHARMACEUTICALS INC · prev qtr: $643.30K

Insider Transactions (Form 4)

Latest BVF INC/IL buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-14 U XOMA Royalty Corp 772,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 412,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 2,773,545 — SEC filing
2026-07-14 U XOMA Royalty Corp 3,635,758 — SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 51,858 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 113,289 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 627,597 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 837,914 $106.50 SEC filing

All insider transactions →

Fund Profile

BVF INC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 44 positions worth $3.91B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 44 positions · $3.91B reported value (Q2 2026)
  • Top 10 holdings = 65.6% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 14.2%
  • Average position size: $88.89M

Sector Tilt

  • Health Care 91.6%
  • Financials 0.1%
  • Materials 0.0%
  • (classified holdings cover 92% of value)

Quarterly Activity

  • Q2 2026: 5 new, 6 added, 9 reduced, 2 exited
  • 24 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 86.4%
Materials 0.0%
Other 13.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 21.75M $956.40M 26.80%
26.80%
Hold
2 5.98M $232.13M 6.51%
6.51%
Hold
3 5.16M $154.08M 4.32%
4.32%
Hold
4 3.19M $151.86M 4.26%
4.26%
Add
5 4.37M $149.41M 4.19%
4.19%
Hold
6 10.40M $121.27M 3.40%
3.40%
Hold
7 3.32M $115.01M 3.22%
3.22%
Reduce
8 5.75M $100.29M 2.81%
2.81%
Add
9 9.14M $98.85M 2.77%
2.77%
Hold
10 2.49M $97.69M 2.74%
2.74%
Add
11 3.63M $86.08M 2.41%
2.41%
Hold
12 4.08M $84.05M 2.36%
2.36%
Reduce
13 3.92M $82.33M 2.31%
2.31%
Hold
14 955.00K $76.88M 2.15%
2.15%
New
15 2.42M $76.33M 2.14%
2.14%
Add
16 1.28M $75.68M 2.12%
2.12%
Add
17 18.83M $75.15M 2.11%
2.11%
Add
18 4.66M $74.53M 2.09%
2.09%
Hold
19 7.57M $60.62M 1.70%
1.70%
Add
20 3.47M $56.77M 1.59%
1.59%
New
21 4.37M $56.76M 1.59%
1.59%
Hold
22 1.19M $51.32M 1.44%
1.44%
New
23 5.87M $49.95M 1.40%
1.40%
Hold
24 8.75M $46.02M 1.29%
1.29%
Hold
25 1.16M $40.81M 1.14%
1.14%
Hold
26 1.57M $38.89M 1.09%
1.09%
Reduce
27 7.00M $34.30M 0.96%
0.96%
Hold
28 10.33M $34.10M 0.96%
0.96%
Hold
29 5.30M $30.49M 0.85%
0.85%
New
30 750.00K $29.24M 0.82%
0.82%
Hold
31 1.52M $29.24M 0.82%
0.82%
Hold
32 2.74M $28.99M 0.81%
0.81%
Hold
33 2.25M $21.23M 0.59%
0.59%
Hold
34 441.53K $18.50M 0.52%
0.52%
Reduce
35 2.99M $17.49M 0.49%
0.49%
Hold
36 6.29M $16.61M 0.47%
0.47%
Add
37 16.55M $16.55M 0.46%
0.46%
Hold
38 8.90M $9.88M 0.28%
0.28%
Hold
39 4.77M $7.87M 0.22%
0.22%
Hold
40 1.81M $7.25M 0.20%
0.20%
Hold
41 2.00M $6.96M 0.20%
0.20%
Hold
42 5.23M $6.38M 0.18%
0.18%
Reduce
43 2.31M $6.24M 0.17%
0.17%
Hold
44 1.69M $5.02M 0.14%
0.14%
Hold
45 343.06K $4.10M 0.12%
0.12%
Reduce
46 650.00K $3.17M 0.09%
0.09%
Hold
47 443.22K $3.17M 0.09%
0.09%
Hold
48 3.85M $2.96M 0.08%
0.08%
Hold
49 917.83K $2.85M 0.08%
0.08%
Hold
50 9.54M $2.69M 0.07%
0.07%
Hold

FAQ

What did BVF INC/IL buy in 2024-Q2?

In its 2024-Q2 13F filing, BVF INC/IL reported 60 equity positions worth $3.57B in aggregate; its largest disclosed positions were MLTX ($956.40M), RVMD ($232.13M), KYMR ($154.08M).

How large is BVF INC/IL's portfolio?

BVF INC/IL reported $3.57B of long equity holdings across 60 positions as of 2024-Q2. Top-10 holdings account for 61.0% of reported value.

What is BVF INC/IL's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bvf-inc-il/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →